The objective of the EFOMP Special Interest Group for Radionuclide Internal Dosimetry (SIG) is to establish a network of medical physicists working in radionuclide dosimetry. The SIG aims to fulfil the need for networking, education, research and professional exchanges in this field. To fulfil these aims, EFOMP SIG_FRID will organise a Symposium on molecular radiotherapy dosimetry in Athens, Greece.

The Symposium will give the opportunity:

  • to review and share ongoing developments in radionuclide imaging and dosimetry;
  • to consider how personalised treatments may improve effectiveness at a time of rapid expansion of theragnostics and molecular radiotherapy
  • to discuss networking and synergies within a muti-disciplinary community at a time of challenge and opportunity.

Invited Speakers (preliminary list – more to come…)

Irène Buvat

Institut Curie, Orsay, France

AI: a game changer in quantitative molecular imaging and clinical dosimetry

Mark Gaze

University College of London, UK

Can dosimetry improve the outcome of molecular radiotherapy for neuroblastoma?

Caroline Stokke

Oslo University Hospital, Norway

Implementation of Dosimetry for Radionuclide Therapy: Results from a European Survey

Jan Tapproge

Royal Marsden Hospital, Sutton, UK

Quantitative imaging and dosimetry of radioiodine in multi-centre clinical trials

Carlo Chiesa

Istituto Nazionale Tumori, Milan, Italy

Dosimetry and clinical outcome in radioembolization: light and shadow

Manuel Bardiès

Institut de Recherche en Cancérologie de Montpellier, France

Implementing QA in clinical dosimetry

Gerhard Glatting

University of Ulm, Germany

Time-Activity Data, Model Fitting and Model Selection in Molecular Radiotherapy Dosimetry

Sponsored by

Organised by

Special Interest Group for Radionuclide Internal Dosimetry

23 Registered Participants

Register to the symposium
Submit your abstract

Venue

Argyriadis hall – National and Kapodistrian University of Athens,

30 Panepistimiou Str., 10679, Athens